Samuel So

Publications

• Medical training fails to prepare providers to care for patients with chronic hepatitis B infection.
  Chao, S. D., Wang, B.- mei, Chang, E. T., Ma, L., & So, S. K. (2015). Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World journal of gastroenterology , 21(22), 6914-6923.
• Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer
  Yung, M. K., Lo, K. W., Yip, C. W., Chung, G. Ty., Tong, C. Yk., & Cheung, S. T. (2015). Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. BMC CANCER, 15.
• Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
  Wang, Z., Wei, W., Sun, C. K., Chua, M. S., & So, S. (2014). Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Liver international : official journal of the International Association for the Study of the Liver.
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Naghavi, M., Wang, H., Lozano, R., Davis, A., Liang, X., & Murray, C. Jl. (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. LANCET, 385(9963), 117-171.
  
• Imaging of hepatocellular carcinoma patient-derived xenografts using Zr-89-labeled anti-glypican-3 monoclonal antibody Yang, X., Liu, H., Sun, C. K., Natarajan, A., Hu, X., & So, S. K. (2014). Imaging of hepatocellular carcinoma patient-derived xenografts using Zr-89-labeled anti-glypican-3 monoclonal antibody. BIOMATERIALS, 35(25), 6964-6971.
  
• Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts. Wei, W., Wu, S., Wang, X., Sun, C. Kw., Yang, X., & So, S. (2014). Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts. Oncotarget, 5(14), 5819-5831.
  
• Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Lu, W.-J., Chua, M.-S., & So, S. K. (2014). Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis, 35(4), 915-922.
  
• Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives Ma, L., Chua, M.-S., Andrisani, O., & So, S. (2014). Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. WORLD JOURNAL OF GASTROENTEROLOGY, 20(2), 333-345.
  
• Wnt pathway activation in hepatocellular carcinoma: A clinical perspective. Ma, L., Wei, W., Chua, M.-S., & So, S. (2014). Wnt pathway activation in hepatocellular carcinoma: A clinical perspective. . Gastrointestinal Cancer: Targets and Therapy, 4.
  
• Glypican-3-Mediates Autophagy and Promotes Self-Renewal and Tumor Initiation of Hepatocellular Carcinoma Cells SUN, Chris., CHUA, Mei.-Sze., WEI, Wei., & SO, Samuel. (2014). Glypican-3-Mediates Autophagy and Promotes Self-Renewal and Tumor Initiation of Hepatocellular Carcinoma Cells. Journal of Stem Cell Research & Therapy, 4(9).
  
• Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment Toy, M., Demirci, U., & So, S. (2014). Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment. Hepatic Oncology, 1(3).
  
• Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. Zhao, P., Yang, X., Qi, S., Liu, H., Jiang, H., & Cheng, Z. (2013). Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. BioMed research international, 2013, 759057-?.
  
• Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california. Yang, E. J., Cheung, C. M., So, S. Ks., Chang, E. T., & Chao, S. D. (2013). Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california. Asian Pacific journal of cancer prevention , 14(3), 1707-1713.
  
• Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma Bu, L., Xie, J., Chen, K., Huang, J., Aguilar, Z. P., & Chen, X. (2012). Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. CONTRAST MEDIA & MOLECULAR IMAGING, 7(4), 363-372.
  
• Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses Chao, S. D., Cheung, C. M., Yang, E. J., So, S. Ks., & Chang, E. T. (2012). Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 41(4), 494-505.
  
• A model program for hepatitis B vaccination and education of schoolchildren in rural China Chen, J. J., Chang, E. T., Chen, Y.- ren, Bailey, M. B., & So, S. Ks. (2012). A model program for hepatitis B vaccination and education of schoolchildren in rural China. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 57(3), 581-588.
  
• Identification of a 14-gene signature that predicts survival in colorectal cancer with liver metastasis Chung, J. L., Pollack, J., Chua, M.-S., So, S., Lin, C.-D., & Lin, A. Y. (2012). Identification of a 14-gene signature that predicts survival in colorectal cancer with liver metastasis. JOURNAL OF CLINICAL ONCOLOGY, 30(15).
  
• The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., & Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662-6667.
  
• MOLECULAR EFFECTS OF SUPPRESSING THE CDC37 COCHAPERONE IN HEPATOCELLULAR CARCINOMA INHIBITS CELL CYCLE PROGRESSION AND CELL GROWTH Wang, Z., Wei, W., Sun, K.-W., Chua, M.-S., & So, S. (2012). MOLECULAR EFFECTS OF SUPPRESSING THE CDC37 COCHAPERONE IN HEPATOCELLULAR CARCINOMA INHIBITS CELL CYCLE PROGRESSION AND CELL GROWTH. JOURNAL OF HEPATOLOGY, 56, S130-S130.
  
• OPTICAL IMAGING OF LIVER CARCINOMA XENOGRAFTS USING EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED FLUORESCENTLY LABELED AFFIBODY Zhao, P., Yang, X., Qi, S., Cao, Q., Chua, M.-S., & Cheng, Z. (2011). OPTICAL IMAGING OF LIVER CARCINOMA XENOGRAFTS USING EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED FLUORESCENTLY LABELED AFFIBODY. HEPATOLOGY, 54, 894A-894A.
  
• Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2 Sun, C. K., Chua, M.-S., He, J., & So, S. K. (2011). Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2. NEOPLASIA, 13(8), 735-U111.
  
• San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer Bailey, M. B., Shiau, R., Zola, J., Fernyak, S. E., Fang, T., & Chang, E. T. (2011). San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer. JOURNAL OF COMMUNITY HEALTH, 36(4), 538-551.
  
• In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma Darpolor, M. M., Yen, Y.-F., Chua, M.-S., Xing, L., Clarke-Katzenberg, R. H., & Spielman, D. M. (2011). In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma. NMR IN BIOMEDICINE, 24(5), 506-513.
  
• Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions Hutton, D. W., Brandeau, M. L., & So, S. K. (2011). Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions. INTERFACES, 41(3), 289-300.
  
• Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker Lin, A. Y., Chua, M.-S., Choi, Y.-L., Yeh, W., Kim, Y. H., & Pollack, J. R. (2011). Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker. PLOS ONE, 6(2).
  
• Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2011). Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. MOLECULAR CANCER, 10.
  
• Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians Chang, E. T., Yang, J., Alfaro-Velcamp, T., So, S. Ks., Glaser, S. L., & Gomez, S. L. (2010). Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 19(12), 3106-3118.
  
• Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo Wei, W., Chua, M.-S., Grepper, S., & So, S. (2010). Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. INTERNATIONAL JOURNAL OF CANCER, 126(10), 2426-2436.
  
• Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease El-Serag, H., McGlynn, K. A., Graham, G. N., So, S., Howell, C. D., & Thiel, T. K. (2010). Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. JOURNAL OF FAMILY PRACTICE, 59(4), S37-S42.
  
• Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study Chao, J., Chang, E. T., & So, S. Ks. (2010). Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC PUBLIC HEALTH.
  
• Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China Hutton, D. W., So, S. K., & Brandeau, M. L. (2010). Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China. HEPATOLOGY, 51(2), 405-414.
  
• Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma Yen, Y., So, S., Rose, M., Saif, M. W., Chu, E., & Cheng, Y.-C. (2009). Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma. ANTICANCER RESEARCH, 29(10), 4083-4092.
  
• Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2009). Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. MOLECULAR CANCER, 8.
  
• The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans Chao, S. D., Chang, E. T., Le, P. V., Prapong, W., Kiernan, M., & So, S. Ks. (2009). The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 11(4), 281-290.
  
• Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms Li, V. Sw., Yuen, S. T., Chan, T. L., Yan, H. Hn., Law, W. L., & Leung, S. Y. (2009). Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms. GASTROENTEROLOGY, 137(1), 176-187.
  
• Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students Lin, S. Y., Chang, E. T., & So, S. K. (2009). Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 383-386.
  
• 3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans Chang, E. T., Sue, E., Zola, J., & So, S. K. (2009). 3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans. AMERICAN JOURNAL OF HEALTH PROMOTION, 23(3), 176-181.
  
• Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action Chao, S. D., Chang, E. T., & So, S. K. (2009). Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 507-512.
  
• N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells Yan, X., Chua, M.-S., Sun, H., & So, S. (2008). N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. CANCER LETTERS, 262(1), 133-142.
  
• Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo Yan, X., Chua, M.-S., He, J., & So, S. K. (2008). Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. MOLECULAR CANCER, 7.
  
• Phase H study of imatinib in unresectable hepatocellular carcinoma Lin, A. Y., Fisher, G. A., So, S., Tang, C., & Levitt, L. (2008). Phase H study of imatinib in unresectable hepatocellular carcinoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 31(1), 84-88.
  
• Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Sun, H., Chua, M. S., Yang, D., Tsalenko, A., Peter, B. J., & So, S. (2008). Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Biomarker insights, 3, 1-18.
  
• Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California Chang, E. T., Nguyen, B. H., & So, S. Ks. (2008). Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 9(4), 605-613.
  
• Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention Chang, E. T., Lin, S. Y., Sue, E., Bergin, M., Su, J., & So, S. Ks. (2007). Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 13(10), 1125-1127.
  
• Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives" Chang, E. T., & So, S. Ks. (2007). Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives". AMERICAN JOURNAL OF EPIDEMIOLOGY, 166(9), 1105-1106.
  
• Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B Hutton, D. W., Tan, D., So, S. K., & Brandeau, M. L. (2007). Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B. ANNALS OF INTERNAL MEDICINE, 147(7), 460-469.
  
• Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California Lin, S. Y., Chang, E. T., & So, S. K. (2007). Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California. HEPATOLOGY, 46(4), 1034-1040.
  
• The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004 Chang, E. T., Keegan, T. Hm., Gomez, S. L., Le, G. M., Clarke, C. A., & Glaser, S. L. (2007). The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004. CANCER, 109(10), 2100-2108.
  
• Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma Chua, M.-S., Sun, H., Cheung, S. T., Mason, V., Higgins, J., & So, S. (2007). Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. MODERN PATHOLOGY, 20(1), 76-83.
  
• Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California Wu, C. A., Lin, S. Y., So, S. K., & Chang, E. T. (2007). Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 8(1), 127-134.
  
• Comprehensive analysis of 19q12 amplicon in human gastric cancers Leung, S. Y., Ho, C., Tu, I.-P., Li, R., So, S., & Chen, X. (2006). Comprehensive analysis of 19q12 amplicon in human gastric cancers. MODERN PATHOLOGY, 19(6), 854-863.
  
• Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma Chua, M.-S., Bernstein, L. R., Li, R., & So, S. Ks. (2006). Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. ANTICANCER RESEARCH, 26(3A), 1739-1743.
  
• Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma Fong, C. W., Chua, M. S., McKie, A. B., Ling, S. Hm., Mason, L., & Guy, G. R. (2006). Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. CANCER RESEARCH, 66(4), 2048-2058.
  
• Topological and functional discovery in a gene coexpression meta-network of gastric cancer Aggarwal, A., Guo, D. L., Hoshida, Y., Yuen, S. T., Chu, K. M., & Tan, P. (2006). Topological and functional discovery in a gene coexpression meta-network of gastric cancer. CANCER RESEARCH, 66(1), 232-241.
  
• Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Patil, M. A., Gutgemann, I., Zhang, J., Ho, C., Cheung, S. T., & Chen, X. (2005). Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. CARCINOGENESIS, 26(12), 2050-2057.
  
• Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment Hsu, C. P., Razavi, M. K., So, S. K., Parachikov, I. H., & Benaron, D. A. (2005). Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 16(11), 1473-1478.
  
• A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC). LIN, A. Y., Fisher, G., So, S., Tang, C., & Levitt, L. (2005). A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC). JOURNAL OF CLINICAL ONCOLOGY, 23(16), 363S-363S.
  
• An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma Patil, M. A., Chua, M. S., Pan, K. H., Lin, R., Lih, C. J., & So, S. (2005). An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. ONCOGENE, 24(23), 3737-3747.
  
• Mutations of PIK3CA in gastric adenocarcinoma Li, V. Sw., Wong, C. W., Chan, T. L., Chan, A. Sw., Zhao, W., & Leung, S. Y. (2005). Mutations of PIK3CA in gastric adenocarcinoma. BMC CANCER, 5.
  
• Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy Cheung, S. T., Ho, J. Cy., Leung, K. L., Chen, X., Fong, D. Yt., & Fan, S. T. (2005). Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. NEOPLASIA, 7(2), 91-98.
  
• Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma Cheung, S. T., Leung, K. L., Ip, Y. C., Chen, X., FONG, D. Y., & So, S. (2005). Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 11(2), 551-556.
  
• Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma Lin, A. Y., Brophy, N., Fisher, G. A., So, S., Biggs, C., & Levitt, L. (2005). Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. CANCER, 103(1), 119-125.
  
• Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma Cheung, S. T., Wong, S. Y., Leung, K. L., Chen, X., So, S., & Fan, S. T. (2004). Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 10(22), 7629-7636.
  
• Novel endothelial cell markers in hepatocellular carcinoma Chen, X., Higgins, J., Cheung, S. T., Li, R., Mason, V., & So, S. (2004). Novel endothelial cell markers in hepatocellular carcinoma. MODERN PATHOLOGY, 17(10), 1198-1210.
  
• Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States. Guane, R., Siu, P., Lam, K., Kim, K. E., Warren, V., & Brosgrat, C. L. (2004). Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States. HEPATOLOGY, 40(4), 716A-716A.
  
• High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California. Chao, S., Le, P. V., Prapong, W., Su, J., & So, S. (2004). High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California. HEPATOLOGY, 40(4), 717A-717A.
  
• Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer Leung, S. Y., Yuen, S. T., Chu, K. M., Mathy, J. A., Li, R., & So, S. (2004). Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. GASTROENTEROLOGY, 127(2), 457-469.
  
• One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience Millan, M. T., Berquist, W. E., So, S. K., Sarwal, M. M., Wayman, K. I., & Esquivel, C. O. (2003). One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience. TRANSPLANTATION, 76(10), 1458-1463.
  
• Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma Chan, A. Sw., Tsui, W. Y., Chen, X., Chu, K. M., Chan, T. L., & Leung, S. Y. (2003). Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. ONCOGENE, 22(44), 6946-6953.
  
• Variation in gene expression patterns in human gastric cancers Chen, X., Leung, S. Y., Yuen, S. T., Chu, K. M., Ji, J. F., & Brown, P. O. (2003). Variation in gene expression patterns in human gastric cancers. MOLECULAR BIOLOGY OF THE CELL, 14(8), 3208-3215.
  
• Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis Leung, S. Y., Chen, X., Chu, K. M., Yuen, S. T., Mathy, J., & Brown, P. O. (2002). Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(25), 16203-16208.
  
• Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines Ji, J. F., Chen, X., Leung, S. Y., Chi, J. Ta., Chu, K. M., & So, S. (2002). Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. ONCOGENE, 21(42), 6549-6556.
  
• Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Kim, P., Prapong, W., Sze, D. Y., So, S. K., & Razavi, M. K. (2002). Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Techniques in vascular and interventional radiology, 5(3), 127-131.
  
• Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor Cheung, S. T., Chen, X., GUAN, X. Y., Wong, S. Y., Tai, L. S., & Fan, S. T. (2002). Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. CANCER RESEARCH, 62(16), 4711-4721.
  
• Gene expression patterns in human liver cancers Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., & Brown, P. O. (2002). Gene expression patterns in human liver cancers. MOLECULAR BIOLOGY OF THE CELL, 13(6), 1929-1939.
  
• Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts Millan, M. T., Natkunam, Y., Clarke-Katzenberg, R., Desai, D., Prapong, W., & Martinez, O. M. (2002). Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts. TRANSPLANTATION, 73(3), 465-469.
  
• Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma Sze, D. Y., Razavi, M. K., So, S. Ks., & Jeffrey, R. B. (2001). Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AMERICAN JOURNAL OF ROENTGENOLOGY, 177(6), 1339-1345.
  
• Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes Kane, R., Solomon, H., Friedman, B., Heffron, T., DePaolo, J., & Spaith, E. (2001). Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. TRANSPLANTATION, 72(3), 463-476.
  
• Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis Lai, K. M., MILLAN, M., Razavi, M., Keeffe, E. B., Prapong, W., & So, S. Ks. (2001). Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1490-1491.
  
• CMV and EBV-PTLD after liver transplantation So, S. (2001). CMV and EBV-PTLD after liver transplantation. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1317-1319.
  
• Genome-wide study of human hepatocellular carcinoma with 23K cDNA microarray. Chen, X., Cheung, S., Barry, C., Fan, S., Lai, K. M., & So, S. (2000). Genome-wide study of human hepatocellular carcinoma with 23K cDNA microarray. HEPATOLOGY, 32(4), 324A-324A.
  
• A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts Millan, M. T., Sarwal, M. M., Lemley, K. V., Yorgin, P., Orlandi, P., & Salvatierra, O. (2000). A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. ARCHIVES OF SURGERY, 135(9), 1063-1068.
  
• Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization. Millan, M. T., Lai, K. M., Keeffe, E. B., Fisher, G. A., Razavi, M. K., & So, S. Ks. (2000). Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization. TRANSPLANTATION, 69(8), S215-S215.
  
• Intravenous ribavirin therapy for adenovirus pneumonia Shetty, A. K., Gans, H. A., So, S., Millan, M. T., Arvin, A. M., & Gutierrez, K. M. (2000). Intravenous ribavirin therapy for adenovirus pneumonia. PEDIATRIC PULMONOLOGY, 29(1), 69-73.
  
• Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients Krieger, N. R., Martinez, O. M., Krams, S. M., Cox, K., So, S., & Esquivel, C. O. (2000). Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. LIVER TRANSPLANTATION, 6(1), 62-66.
  
• CD81 gene expression is lost in hepatocellular carcinoma. Drazan, K. E., Higgins, J., Fisher, G. A., Keefe, E., Barry, C. T., & Esquivel, C. O. (1999). CD81 gene expression is lost in hepatocellular carcinoma. HEPATOLOGY, 30(4), 248A-248A.
  
• Resection versus transplantation for hepatocellular carcinoma Esquivel, C. O., Keeffe, E. B., Garcia, G., Imperial, J. C., Millan, M. T., & So, S. K. (1999). Resection versus transplantation for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S37-S41.
  
• Major hepatic resection without blood transfusion: Experience with total vascular exclusion So, S. K., Monge, H., & Esquivel, C. O. (1999). Major hepatic resection without blood transfusion: Experience with total vascular exclusion. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S28-S31.
  
• Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? So, S. K., Esquivel, C. O., Imperial, J. C., Garcia, G., Monge, H., & Keeffe, E. B. (1999). Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, S48-S52.
  
• Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays. Barry, C. T., MILLAN, M., Monge, H., Esquivel, C., BROWN, P., & So, S. (1999). Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays. TRANSPLANTATION, 67(7), S142-S142.
  
• Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Cao, S., Cox, K. L., Berquist, W., Hayashi, M., Concepcion, W., & Esquivel, C. O. (1999). Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatric transplantation, 3(1), 22-26.
  
• Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Busque, S., & Esquivel, C. O. (1999). Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. ARCHIVES OF SURGERY, 134(1), 25-29.
  
• Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients Cao, S., Cox, K. L., Berquist, W., So, S., Concepcion, W., & Esquivel, C. O. (1998). Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients. TRANSPLANTATION PROCEEDINGS, 30(8), 4322-4324.
  
• Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., & Wiesner, R. H. (1998). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation, 66(7), 956-962.
  
• Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation Cao, S., Cox, K., Esquivel, C. O., Berquist, W., Concepcion, W., & So, S. (1998). Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. TRANSPLANTATION, 66(7), 851-856.
  
• Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis So, S. Ks., Esquivel, C. O., Imperial, J. C., Garcia, G., & Keeffe, E. B. (1998). Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis. HEPATOLOGY, 28(4), 346A-346A.
  
• Liver transplantation in the first three months of life Woodle, E. S., Millis, J. M., So, S. Ks., McDiarmid, S. V., Busuttil, R. W., & Thistlethwaite, J. R. (1998). Liver transplantation in the first three months of life. TRANSPLANTATION, 66(5), 606-609.
  
• Allograft rejection after liver transplantation for autoimmune liver diseases Hayashi, M., Keeffe, E. B., Krams, S. M., Martinez, O. M., Ojogho, O. N., & Esquivel, C. O. (1998). Allograft rejection after liver transplantation for autoimmune liver diseases. LIVER TRANSPLANTATION AND SURGERY, 4(3), 208-214.
  
• Indications for pediatric liver transplantation. McDiarmid, S. V., Millis, M. J., Olthoff, K. M., & So, S. K. (1998). Indications for pediatric liver transplantation. Pediatric transplantation, 2(2), 106-116.
  
• Current status of living-related liver transplantation. Hayashi, M., Cao, S., Concepcion, W., Monge, H., Ojogho, O., & Esquivel, C. O. (1998). Current status of living-related liver transplantation. Pediatric transplantation, 2(1), 16-25.
  
• Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation Busque, S., Esquivel, C. O., Concepcion, W., & So, S. Ks. (1998). Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. TRANSPLANTATION, 65(1), 77-82.
  
• Liver transplantation at Stanford University Medical Center. Millan, M. T., Keeffe, E. B., Berquist, W. E., Castillo, R. O., Cox, K. L., & Esquivel, C. O. (1998). Liver transplantation at Stanford University Medical Center. Clinical transplants, 287-296.
  
• Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., & Wiesner, R. H. (1997). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver transplantation and surgery , 3(6), 628-637.
  
• Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy Wang, J., Cox, K. L., Dake, M., Esquivel, C. O., & So, S. Ks. (1997). Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 25(4), 421-425.
  
• Superior outcomes in pediatric renal transplantation Salvatierra, O., Alfrey, E., Tanney, D. C., Mak, R., Hammer, G. B., & Conley, S. B. (1997). Superior outcomes in pediatric renal transplantation. ARCHIVES OF SURGERY, 132(8), 842-847.
  
• Factors affecting survival after orthotopic liver transplantation in infants Cacciarelli, T. V., Esquivel, C. O., Moore, D. H., Cox, K. L., Berquist, W. E., & So, S. Ks. (1997). Factors affecting survival after orthotopic liver transplantation in infants. TRANSPLANTATION, 64(2), 242-248.
  
• Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients Cao, S., Cox, K., So, S. Sk., Berquist, W., Lee, S. P., & Esquivel, C. O. (1997). Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. DIGESTIVE DISEASES AND SCIENCES, 42(7), 1409-1415.
  
• Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions Tojimbara, T., Winston, W. N., So, S. K., & Esquivel, C. O. (1997). Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions. TRANSPLANTATION PROCEEDINGS, 29(1-2), 1371-1373.
  
• Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report Cao, S., Monge, H., Semba, C., Cox, K. L., Berquist, W., & Esquivel, C. O. (1997). Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report. JOURNAL OF PEDIATRIC SURGERY, 32(1), 125-127.
  
• Liver transplantation in Asian patients with chronic hepatitis B HO, B. M., So, S. K., Esquivel, C. O., & Keeffe, E. B. (1997). Liver transplantation in Asian patients with chronic hepatitis B. HEPATOLOGY, 25(1), 223-225.
  
• Primary liver transplantation without transfusion of red blood cells Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, P., & Esquivel, C. O. (1996). Primary liver transplantation without transfusion of red blood cells. SURGERY, 120(4), 698-704.
  
• Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival Ojogho, O. N., So, S. Ks., Keeffe, E. B., Berquist, W., Concepcion, W., & Esquivel, C. O. (1996). Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival. ARCHIVES OF SURGERY, 131(9), 935-939.
  
• Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation Hammer, G. B., So, S. Ks., ALUZRI, A., Conley, S. B., Concepcion, W., & Esquivel, C. O. (1996). Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation. TRANSPLANTATION, 62(1), 130-132.
  
• Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro Tojimbara, T., Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., & Esquivel, C. O. (1996). Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro. TRANSPLANTATION PROCEEDINGS, 28(3), 1381-1382.
  
• Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation Cacciarelli, T. V., Esquivel, C. O., Cox, K. L., Hayashi, M., Berquist, W. E., & So, S. Ks. (1996). Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. TRANSPLANTATION, 61(8), 1188-1192.
  
• Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients Esquivel, C. O., So, S. K., McDiarmid, S. V., Andrews, W. S., & Colombani, P. M. (1996). Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. TRANSPLANTATION, 61(5), 847-848.
  
• Expression of cytokines and immune mediators during chronic liver allograft rejection Hayashi, M., Martinez, O. M., GARCIAKENNEDY, R., So, S., Esquivel, C. O., & Krams, S. M. (1995). Expression of cytokines and immune mediators during chronic liver allograft rejection. TRANSPLANTATION, 60(12), 1533-1538.
  
• THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION Tojimbara, T., Kennedy, R. G., BURNS, W., Hayashi, M., Krams, S., & Esquivel, C. O. (1995). THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(10), 1179-1180.
  
• FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR Tojimbara, T., So, S. K., Cox, K. L., Berquist, W. E., Egawa, H., & Esquivel, C. O. (1995). FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR. TRANSPLANTATION, 60(9), 1052-1053.
  
• A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION Cacciarelli, T. V., So, S. Ks., Lim, J., Concepcion, W., Cox, K., & Esquivel, C. O. (1995). A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(7), 757-760.
  
• LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA Lang, T., Berquist, W. E., So, S. K., Cox, K. L., RICH, E. J., & Esquivel, C. O. (1995). LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA. TRANSPLANTATION, 59(10), 1490-1492.
  
• EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION Kozaki, K., Egawa, H., Bermudez, L., Keefe, E. B., So, S. K., & Esquivel, C. O. (1995). EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION. HEPATOLOGY, 21(4), 1079-1082.
  
• ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA Egawa, H., Berquist, W., So, S. K., Cox, K., Menegaux, F., & Esquivel, C. O. (1995). ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA. TRANSPLANTATION, 59(5), 791-793.
  
• FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL McDiarmid, S. V., Busuttil, R. W., Ascher, N. L., Burdick, J., DALESSANDRO, A. M., & So, S. K. (1995). FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL. TRANSPLANTATION, 59(4), 530-536.
  
• AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION Cox, K. L., LAWRENCEMIYASAKI, L. S., GARCIAKENNEDY, R., Lennette, E. T., Martinez, O. M., & Esquivel, C. O. (1995). AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION. TRANSPLANTATION, 59(4), 524-529.
  
• DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., & Martinez, O. M. (1995). DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION, 59(4), 584-589.
  
• IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION Cacciarelli, T. V., So, S. Ks., Egawa, H., Cox, K., & Esquivel, C. O. (1995). IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION. TRANSPLANTATION PROCEEDINGS, 27(1), 1239-1240.
  
• CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION Egawa, H., Martinez, O. M., QUINN, M. B., So, S., Esquivel, C. O., & Krams, S. M. (1995). CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 27(1), 505-506.
  
• FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH Woodle, E. S., Perdrizet, G. A., So, S. Ks., White, H. M., & Marsh, J. W. (1995). FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH. CLINICAL TRANSPLANTATION, 9(1), 45-52.
  
• LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., & Krams, S. M. (1995). LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED. TRANSPLANTATION PROCEEDINGS, 27(1), 241-242.
  
• MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS Martinez, O. M., Villanueva, J. C., LAWRENCEMIYASAKI, L., QUINN, M. B., Gish, R., & Krams, S. M. (1995). MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1211-1212.
  
• CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS Lang, T., Krams, S. M., Villanueva, J. C., So, S. K., Berquist, W. E., & Martinez, O. M. (1995). CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1148-1149.
  
• DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., & Martinez, O. M. (1995). DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1146-1147.
  
• ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., & Krams, S. M. (1995). ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE. TRANSPLANTATION, 59(1), 97-102.
  
• EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION Wong, L., Concepcion, W., So, S. K., Egawa, H., Menegaux, F., & Esquivel, C. O. (1994). EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 179(5), 601-603.
  
• NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS Menegaux, F., Keeffe, E. B., Andrews, B. T., Egawa, H., Monge, H., & Esquivel, C. O. (1994). NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS. TRANSPLANTATION, 58(4), 447-450.
  
• RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION Egawa, H., Berquist, W., GARCIAKENNEDY, R., Cox, K. L., Concepcion, W., & Esquivel, C. O. (1994). RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 19(1), 114-117.
  
• FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION Egawa, H., Esquivel, C. O., So, S. K., Cox, K., Concepcion, W., & Lawrence, L. (1994). FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 57(8), 1169-1173.
  
• PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS Conley, S. B., ALUZRI, A., So, S., & Salvatierra, O. (1994). PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS. TRANSPLANTATION, 57(4), 540-544.
  
• INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION Hanto, D. W., Jendrisak, M. D., So, S. Ks., McCullough, C. S., Rush, T. M., & Mohanakumar, T. (1994). INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION. TRANSPLANTATION, 57(3), 377-384.
  
• AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION ALUZRI, A., Conley, S. B., Orlandi, P., So, S., & Salvatierra, O. (1994). AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 26(1), 88-90.
  
• Liver transplantation at California Pacific Medical Center, San Francisco, California. Esquivel, C. O., Martinez, O., Krams, S., Lim, J., So, S. K., & Keeffe, E. B. (1994). Liver transplantation at California Pacific Medical Center, San Francisco, California. Clinical transplants, 163-171.
  
• PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION Kozaki, K., Egawa, H., BERMUDES, L., Feduska, N. J., So, S., & Esquivel, C. O. (1993). PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3025-3026.
  
• COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION Menegaux, F., Egawa, H., Keeffe, E. B., So, S. K., Concepcion, W., & Esquivel, C. O. (1993). COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3196-3198.
  
• OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT Bunchman, T. E., Kershaw, D. B., Merion, R. M., Ham, J. M., Sedman, A. B., & So, S. Ks. (1993). OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT. CLINICAL TRANSPLANTATION, 7(3), 219-222.
  
• FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY. TRANSPLANTATION PROCEEDINGS, 25(2), 1990-1991.
  
• RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION Woodle, E. S., So, S., Jendrisak, M. D., Perdrizet, G. A., White, H. M., & Marsh, J. W. (1993). RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 25(2), 1988-1989.
  
• SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE So, S. Ks., BARTEAU, J. A., Perdrizet, G. A., & Marsh, J. W. (1993). SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE. TRANSPLANTATION PROCEEDINGS, 25(2), 1962-1963.
  
• FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE. TRANSPLANTATION PROCEEDINGS, 25(2), 1992-1993.
  
• INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION Woodle, E. S., Darcy, M., White, H. M., Perdrizet, G. A., Vesely, T. M., & Marsh, J. W. (1993). INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION. SURGERY, 113(3), 344-351.
  
• CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS So, S., Mayo, C., McCullough, C., Jendrisak, M., Woodle, S., & Bailey, T. (1993). CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 25(1), 1414-1415.
  
• FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. Ks., Jendrisak, M. D., & Marsh, J. W. (1992). FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION, 54(2), 377-381.
  
• EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS Schnaper, H. W., COTTEL, J., Merrill, S., Marcusson, E., Kissane, J. M., & Schneider, J. A. (1992). EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS. JOURNAL OF PEDIATRICS, 120(4), 575-578.
  
• QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506 Johnson, M. C., So, S., Marsh, J. W., & Murphy, A. M. (1992). QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506. TRANSPLANTATION, 53(4), 929-930.
  
• FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. Ks., Jendrisak, M. D., & Marsh, J. W. (1991). FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(6), 2992-2993.
  
• ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT Beebe, D. S., Belani, K. G., MERGENS, P., Liao, J. C., So, S. Ks., & PALAHNIUK, R. J. (1991). ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT. ANESTHESIA AND ANALGESIA, 73(6), 725-730.
  
• RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE Goss, J. A., Cole, B. R., Jendrisak, M. D., McCullough, C. S., So, S. Ks., & Hanto, D. W. (1991). RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE. TRANSPLANTATION, 52(5), 805-810.
  
• LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE McCullough, C. S., Soper, N. J., Clayman, R. V., So, S. Sk., Jendrisak, M. D., & Hanto, D. W. (1991). LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE. TRANSPLANTATION, 51(3), 725-727.
  
• SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION Jendrisak, M., Phelan, D., Marsh, J., McCullough, C., So, S., & Hanto, D. (1991). SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 434-436.
  
• SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS Najarian, J. S., Frey, D. J., Matas, A. J., So, S. Ks., Cook, M., & Nevins, T. E. (1991). SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1382-1383.
  
• A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS Hanto, D. W., Jendrisak, M. D., McCullough, C. S., So, S. Ks., Marsh, J. W., & Mohanakumar, T. (1991). A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1050-1051.
  
• SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION So, S. Ks., MOUDRYMUNNS, K. C., Gillingham, K., Minford, E. J., & Sutherland, D. Er. (1991). SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 1634-1636.
  
• THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN So, S. Ks., Gillingham, K., Cook, M., Mauer, S. M., Matas, A., & Najarian, J. S. (1990). THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN. TRANSPLANTATION, 50(6), 979-983.
  
• RENAL-TRANSPLANTATION IN INFANTS Najarian, J. S., Frey, D. J., Matas, A. J., Gillingham, K. J., So, S. Sk., & Nevins, T. E. (1990). RENAL-TRANSPLANTATION IN INFANTS. ANNALS OF SURGERY, 212(3), 353-367.
  
• REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE Castaneda, F., So, S. Ks., Hunter, D. W., CASTANEDAZUNIGA, W. R., & Amplatz, K. (1990). REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 13(2), 88-90.
  
• DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS So, S. Ks., Minford, E. J., MOUDRYMUNNS, K. C., Gillingham, K., & Sutherland, D. Er. (1990). DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS. TRANSPLANTATION PROCEEDINGS, 22(2), 687-688.
  
• INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL Bumgardner, G. L., Billiar, T., So, S. K., Chen, S., Dunn, G., & Ascher, N. L. (1989). INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL. TRANSPLANTATION PROCEEDINGS, 21(1), 1154-1155.
  
• AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES Bumgardner, G. L., Chen, S., Hoffman, R., Cahill, D. C., So, S. K., & Ascher, N. L. (1989). AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES. TRANSPLANTATION, 47(1), 163-170.
  
• LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION So, S. Ks., Najarian, J. S., Nevins, T. E., FRYD, D. S., Knaak, M., & SIMMONS, R. L. (1987). LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 111(6), 1017-1021.
  
• MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS Platt, J. L., Ascher, N. L., Snover, D. C., & So, S. Ks. (1987). MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(4), 66-67.
  
• DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT Hunter, D. W., & So, S. K. (1987). DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT. RADIOLOGIC CLINICS OF NORTH AMERICA, 25(2), 249-260.
  
• GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION So, S. Ks., Chang, P. N., Najarian, J. S., Mauer, S. M., SIMMONS, R. L., & Nevins, T. E. (1987). GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 110(3), 343-350.
  
• 1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER Najarian, J. S., So, S. Ks., SIMMONS, R. L., Mauer, S. M., Nevins, T. E., & FRYD, D. S. (1987). 1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER. TRANSPLANTATION PROCEEDINGS, 19(1), 2111-2112.
  
• CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS So, S. Ks., Snover, D. C., Ascher, N. L., & Platt, J. L. (1987). CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(1), 2464-2465.
  
• PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE So, S. Ks., Wilkes, L. M., Platt, J. L., Ascher, N. L., & SIMMONS, R. L. (1987). PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE. TRANSPLANTATION PROCEEDINGS, 19(1), 251-252.
  
• A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS FRYD, D. S., So, S. Ks., Kruse, L., Canafax, D. M., Sutherland, D. Er., & Najarian, J. S. (1987). A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS. TRANSPLANTATION PROCEEDINGS, 19(1), 1530-1531.
  
• INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS So, S. Ks., Platt, J. L., Ascher, N. L., & Snover, D. C. (1987). INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS. TRANSPLANTATION, 43(1), 79-85.
  
• Renal transplantation at the University of Minnesota during the 1980s. FRYD, D. S., MIGLIORI, R., SIMMONS, R. L., Chavers, B., Dunn, D., & Mauer, S. M. (1987). Renal transplantation at the University of Minnesota during the 1980s. Clinical transplants, 167-181.
  
• THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985) Najarian, J. S., So, S. Ks., SIMMONS, R. L., FRYD, D. S., Nevins, T. E., & Mauer, S. M. (1986). THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985). ANNALS OF SURGERY, 204(3), 246-258.
  
• CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA So, S. Ks., Mauer, S. M., Nevins, T. E., FRYD, D. S., Sutherland, D. Er., & Najarian, J. S. (1986). CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA. KIDNEY INTERNATIONAL, S25-S30.
  
• PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION Nevins, T. E., Knaak, M., So, S. Ks., Chavers, B., Melvin, T., & Najarian, J. S. (1986). PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION. INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 7(2), 91-94.
  
• HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES So, S. Ks., Harty, J. T., Hoffman, R. A., Platt, J. L., BIEL, L. W., & SIMMONS, R. L. (1985). HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES. SURGICAL FORUM, 36, 331-333.
  
• PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE So, S. Ks., Nevins, T. E., Chang, P. N., Mauer, S. M., Ascher, N. L., & Najarian, J. S. (1985). PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE. TRANSPLANTATION PROCEEDINGS, 17(1), 182-183.
  
• THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY Sutherland, D. Er., FRYD, D. S., So, S. Ks., Strand, M., Ascher, N. L., & Najarian, J. S. (1985). THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION PROCEEDINGS, 17(1), 136-137.
  
• THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY Young, A. T., Hunter, D. W., CASTANEDAZUNIGA, W. R., So, S. Ks., Mercado, S., & Amplatz, K. (1985). THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY. RADIOLOGY, 154(3), 639-642.
  
• IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN So, S. Ks., SIMMONS, R. L., FRYD, D. S., Najarian, J. S., & Mauer, S. M. (1985). IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN. SURGERY, 98(4), 729-737.
  
• IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES Harty, J. T., So, S. Ks., Keller, G. A., Hoffman, R., Ascher, N. L., & SIMMONS, R. L. (1985). IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES. TRANSPLANTATION PROCEEDINGS, 17(1), 606-607.
  
• LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY Sutherland, D. Er., FRYD, D. S., So, S. Ks., Bentley, F. R., Ascher, N. L., & Najarian, J. S. (1984). LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION, 38(6), 619-624.
  
• HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE So, S. Ks., Mahan, J. D., Mauer, S. M., Sutherland, D. Er., & Nevins, T. E. (1984). HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 30, 619-623.
  
• FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY Hunter, D. W., So, S. Ks., CASTANEDAZUNIGA, W. R., Coleman, C. E., Sutherland, D. Er., & Amplatz, K. (1983). FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY. RADIOLOGY, 149(1), 105-109.
  
• BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY So, S. Ks., Lindahl, J. A., Sharp, H. L., Cook, A. M., & Leonard, A. S. (1983). BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY. PEDIATRICS, 71(3), 402-405.
  
• HBV markers in Chinese in Hong Kong. Lam, K. C., Yuen, P., COLBOURNE, M. J., Chang, J., & So, S. (1980). HBV markers in Chinese in Hong Kong. Annals of the Academy of Medicine, Singapore, 9(2), 149-151.
  
• COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA So, S. Ks., Song, C. W., Rios, A., & SIMMONS, R. L. (1977). COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA. JOURNAL OF SURGICAL ONCOLOGY, 9(6), 527-540.